0001382963-18-000144.txt : 20181107 0001382963-18-000144.hdr.sgml : 20181107 20181107182413 ACCESSION NUMBER: 0001382963-18-000144 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181105 FILED AS OF DATE: 20181107 DATE AS OF CHANGE: 20181107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOEHR MATTHEW W CENTRAL INDEX KEY: 0001237556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37428 FILM NUMBER: 181167723 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES RD #200 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RITTER PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001460702 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263474527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1880 CENTURY PARK EAST, SUITE 1000 CITY: LOS ANGELES STATE: CA ZIP: 90067 BUSINESS PHONE: 310-203-1000 MAIL ADDRESS: STREET 1: 1880 CENTURY PARK EAST, SUITE 1000 CITY: LOS ANGELES STATE: CA ZIP: 90067 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-11-05 0001460702 RITTER PHARMACEUTICALS INC RTTR 0001237556 FOEHR MATTHEW W RITTER PHARMACEUTICALS, INC. 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES, CA 90067 1 0 0 0 Series B convertible preferred stock 1.30 2018-11-05 4 P 0 100 A 2018-11-05 Common Stock 76923 100 D Warrant Shares (right to buy) 1.30 2018-11-05 4 P 0 38461 A 2018-11-05 2023-11-05 Common Stock 38461 38461 D The Series B convertible preferred stock has no expiration date. The Reporting Person purchased the shares of Series B convertible preferred stock (the "Series B Shares") from the Issuer in a private placement by the Issuer at a stated price of $1,000 per share and received, in addition to the Series B Shares, a warrant to purchase a number of shares of common stock equal to 50% of the aggregate number of shares of common stock into which his Series B Shares are initally convertible, for no additional consideration. /s/Andrew J. Ritter, attorney-in-fact 2018-11-07